abs42.txt	background		for	successful	endoscopic	treatment	of	early	gastric	cancer	(egc)	absolute	criteria	for	a	curative	en	bloc	resection	were	initially	established	toinclude	predominantly	differentiated	mucosal	lesions	≤	2	cm	in	diameter	withoutulceration		these	indications	were	subsequently	expanded	to	include	larger	ulcerated		and	predominantly	undifferentiated	mucosal	lesions		in	addition	differentiated	type	adenocarcinomas	≤	3	cm	with	slight	submucosal	invasion	of<	500	µm	(pt1b1)	are	regarded	as		curative		under	the	expanded	criteria		however	data	derived	from	studies	of	surgical	specimens	in	patients	with	pt1b1	egc	haveyielded	varying	rates	of	lymph	node	metastasis	(lnm)	method		a	systemic	review	was	conducted	using	the	pooled	analysis	to	calculatethe	incidence	of	lnm	in	pt1b1	egc		and	to	investigate	whether	using	a	cut-offvalue	of	<	300	µm	would	decrease	the	risk	of	lnm	in	patients	with	submucosal	egc	results		nineteen	articles	were	included		1507	patients	with	pt1b1	egc	met	theexpanded	indications		the	incidence	of	lnm	was	3%	(45	out	of	1507	patients)		in	asubgroup	analysis	of	three	studies		there	was	no	significant	difference	in	thelnm	between	pt1b	egc	<	300	µm	and	<	500	µm	[3/121(2	5%)	vs		5/180	(2	8%)]	(or0	89		95%	ci	0	22-3	54)	conclusion		overall		expanding	the	indications	for	endoscopic	resection	of	egc	toinclude	lesions	≤	3	cm	t1b1	is	associated	with	a	potential	risk	of	lnm	of	3%		incountries	outside	of	japan		we	found	a	slightly	higher	risk	of	lnm	(4	0%)		theseestimates	of	lnm	should	be	incorporated	into	decisions	regarding	furthermanagement	of	patients	with	egc	≤	3	cm	who	are	found	to	have	slight	submucosalinvasion	(<	500	µm)	in	an	esd	specimen		standardization	of	specimen	handling	andhistological	evaluation	is	essential	if	the	japanese	results	of	endoscopictreatment	for	egc	are	to	be	successfully	applied	in	other	parts	of	the	world	
